| Tracy Anderson, OTR | |
|
1050 Division St, Mauston, WI 53948 | |
| (608) 847-6161 | |
| Not Available |
| Full Name | Tracy Anderson |
|---|---|
| Gender | Female |
| Speciality | Occupational Therapist |
| Location | 1050 Division St, Mauston, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073668513 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225X00000X | Occupational Therapist | 3497-026 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tracy Anderson, OTR N11636 12th Ave, Necedah, WI 54646 Ph: () - | Tracy Anderson, OTR 1050 Division St, Mauston, WI 53948 Ph: (608) 847-6161 |
News Archive
New approaches to the study of vision both from the neurobiological perspective and with a view to the technological development of artificial vision systems: that is the key result of the research project conducted by SISSA in Trieste in collaboration with the Istituto Italiano di Tecnologia in Rovereto and published in the science journal eLife.
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
Baron & Budd, P.C. attorney John Langdoc expressed his support and enthusiasm for a new and innovative initiative by the Washington, D.C.-based Lung Cancer Alliance —called Give a Scan—to make CT Scans and clinical data donated by cancer patients easily accessible to lung cancer researchers. LCA would "de-identify" the scans and data before making the information available to researchers.
iCo Therapeutics Inc. is pleased to announce that an overview of iCo-007, entitled "iCo-007 a VEGF "+" Agent for the Potential Treatment of Diabetic Macular Edema and Diabetic Retinopathy" will be presented at the 8th International Symposium on Ocular Pharmacology and Therapeutics ("ISOPT"), a major international ocular conference.
The School of Medicine at the University of California, Riverside, will serve as lead site for a Phase 2 clinical trial evaluating ecopipam, an investigational first-in-class drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients.
› Verified 3 days ago
Stacey Boyes, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1050 Division St, Mauston, WI 53948 Phone: 608-847-1422 | |
Ms. Jacqueline Rice Weber, OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1050 Division St, Mauston, WI 53948 Phone: 608-847-6161 | |
Bobbi Eckerman, MA,OTR Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1050 Division St., Mauston, WI 53948 Phone: 608-847-6161 | |
Lindsey Lierman, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1050 Division St, Mauston, WI 53948 Phone: 608-847-6161 | |
Kendall Erin Simmons, OTR/L, CLT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1111 North Rd, Mauston, WI 53948 Phone: 608-847-4438 |